블로그

• [U.S. FDA] FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Dise Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) to reduce daily cornstarch intake as an adjunct to nutritional management in adults and pediatric patients 8 years of blog.naver.com · 2026.08.21

동영상

• ▶ Oil Remains Primary Risk Driving Higher Rates Says Haworth Bloomberg Podcasts · 2026.09.18
• ▶ John Ternus takes helm as Tim Cook steps aside as Apple CEO USA TODAY · 2026.09.01